Monday, 27 February 2012

Rheumatoid Arthritis-Pharma Research-Science

Pharma research not always more positive on drugs

NEW YORK (Reuters Health) - Drugmaker-funded science isn't always more likely to favor new medicines than studies paid for by non-profits, according to a new report on past research in rheumatoid arthritis. The finding flies in the face of a large body of evidence showing industry studies tend to promote new drugs and downplay potential side effects. That potential bias has fueled concerns that medical care could be guided by warped science, not least because more and more research is being done or paid for by companies with money riding on the results. ... read more..

No comments:

Post a Comment